UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function

International journal of impotence research, 2006-01, Vol.18 (1), p.77-81

2006

Volltextzugriff (PDF)

SCREENING AND MONITORING FOR BLADDER CANCER: REFINING THE USE OF NMP22

The Journal of urology, 2001-07, Vol.166 (1), p.75-78

2001

Volltextzugriff (PDF)

Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results

Urology (Ridgewood, N.J.), 1999-11, Vol.54 (5), p.884-890

1999

Volltextzugriff (PDF)

Role of viagra after radical prostatectomy

Urology (Ridgewood, N.J.), 2000-02, Vol.55 (2), p.241-245

2000

Volltextzugriff (PDF)

Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis

International journal of impotence research, 2005-01, Vol.17 (1), p.86-90

2005

Volltextzugriff (PDF)

Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis

International journal of impotence research, 2003-10, Vol.15 (5), p.318-322

2003

Volltextzugriff (PDF)

Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer

Urology (Ridgewood, N.J.), 1999-08, Vol.54 (2), p.308-312

1999

Volltextzugriff (PDF)

No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients

Urology (Ridgewood, N.J.), 2000-07, Vol.56 (1), p.92-95

2000

Volltextzugriff (PDF)

Defining sexual outcomes after treatment for localized prostate carcinoma

Cancer, 2002-10, Vol.95 (8), p.1773-1785

2002

Volltextzugriff (PDF)

Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: A differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray

Human pathology, 2001-12, Vol.32 (12), p.1392-1397

2001

Volltextzugriff (PDF)

Comparison of the Efficacy of Local Therapies for Localized Prostate Cancer in the Prostate-Specific Antigen Era: A Large Single-Institution Experience With Radical Prostatectomy and External-Beam Radiotherapy

Journal of clinical oncology, 2002-08, Vol.20 (16), p.3376-3385

2002

Volltextzugriff (PDF)

Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder

BJU international, 2006-05, Vol.97 (5), p.997-1001

2006

Volltextzugriff (PDF)

Urethral catheter removal 3 days after radical retropubic prostatectomy is feasible and desirable

Prostate cancer and prostatic diseases, 2002-12, Vol.5 (4), p.291-295

2002

Volltextzugriff (PDF)

Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level ≤ 10 ng/ml: Radiation therapy or surgery?

International journal of radiation oncology, biology, physics, 1997-07, Vol.38 (4), p.723-729

1997

Volltextzugriff (PDF)

Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer

Urology (Ridgewood, N.J.), 2004-06, Vol.63 (6), p.1138-1142

2004

Volltextzugriff (PDF)

Saturation Technique Does Not Improve Cancer Detection as an Initial Prostate Biopsy Strategy

The Journal of urology, 2006-02, Vol.175 (2), p.485-488

2006

Volltextzugriff (PDF)

NOMOGRAMS INCLUDING NUCLEAR MATRIX PROTEIN 22 FOR PREDICTION OF DISEASE RECURRENCE AND PROGRESSION IN PATIENTS WITH Ta, T1 OR CIS TRANSITIONAL CELL CARCINOMA OF THE BLADDER

The Journal of urology, 2005-05, Vol.173 (5), p.1518-1525

2005

Volltextzugriff (PDF)

Cryosurgery of the prostate : techniques and pitfalls

Urologic clinics of North America, 1996-02, Vol.23 (1), p.147-163

ZIPPE, C. D

1996

Volltextzugriff (PDF)

The use of treatments for erectile dysfunction among survivors of prostate carcinoma

Cancer, 2002-12, Vol.95 (11), p.2397-2407

2002

Volltextzugriff (PDF)

Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma

The Prostate, 1992, Vol.20 (2), p.123-131

1992

Volltextzugriff (PDF)

NMP22 IS A SENSITIVE, COST-EFFECTIVE TEST IN PATIENTS AT RISK FOR BLADDER CANCER

The Journal of urology, 1999, Vol.161 (1), p.62-65

1999

Volltextzugriff (PDF)

Finding help for sexual problems after prostate cancer treatment: A phone survey of men's and women's perspectives

Psycho-oncology (Chichester, England), 2003-07, Vol.12 (5), p.463-473

2003

Volltextzugriff (PDF)

PROSTATE CANCER DETECTION WITH OFFICE BASED SATURATION BIOPSY IN A REPEAT BIOPSY POPULATION

The Journal of urology, 2004-07, Vol.172 (1), p.94-97

2004

Volltextzugriff (PDF)

Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer

Urology (Ridgewood, N.J.), 1996-08, Vol.48 (2), p.249-260

1996

Volltextzugriff (PDF)

Continuing trends in pathological stage migration in radical prostatectomy specimens

Urologic oncology, 2004-07, Vol.22 (4), p.300-306

2004

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieFlow Measurement And Instrumentation

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function

SCREENING AND MONITORING FOR BLADDER CANCER: REFINING THE USE OF NMP22

Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results

Role of viagra after radical prostatectomy

Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis

Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis

Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer

No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients

Defining sexual outcomes after treatment for localized prostate carcinoma

Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: A differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray

Comparison of the Efficacy of Local Therapies for Localized Prostate Cancer in the Prostate-Specific Antigen Era: A Large Single-Institution Experience With Radical Prostatectomy and External-Beam Radiotherapy

Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder

Urethral catheter removal 3 days after radical retropubic prostatectomy is feasible and desirable

Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level ≤ 10 ng/ml: Radiation therapy or surgery?

Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer

Saturation Technique Does Not Improve Cancer Detection as an Initial Prostate Biopsy Strategy

NOMOGRAMS INCLUDING NUCLEAR MATRIX PROTEIN 22 FOR PREDICTION OF DISEASE RECURRENCE AND PROGRESSION IN PATIENTS WITH Ta, T1 OR CIS TRANSITIONAL CELL CARCINOMA OF THE BLADDER

Cryosurgery of the prostate : techniques and pitfalls

The use of treatments for erectile dysfunction among survivors of prostate carcinoma

Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma

NMP22 IS A SENSITIVE, COST-EFFECTIVE TEST IN PATIENTS AT RISK FOR BLADDER CANCER

Finding help for sexual problems after prostate cancer treatment: A phone survey of men's and women's perspectives

PROSTATE CANCER DETECTION WITH OFFICE BASED SATURATION BIOPSY IN A REPEAT BIOPSY POPULATION

Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer

Continuing trends in pathological stage migration in radical prostatectomy specimens

Aktive Filter

Suchergebnisse filtern